Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men

摘要

PurposeTo investigate the potential benefits of testosterone administration to elderly men (>65 years) with late-onset hypogonadism (LOH) in comparison with younger men and to assess the safety of testosterone administration to elderly men.